Martín SJA, Calderón LGY, Zapata VRE, Novelo TJF

Language: Spanish
References: 20
Page: 191-195
PDF size: 139.89 Kb.

ABSTRACT

Objective: to determine the prevalence and factors associated with sarcopenia in the elderly attending a family medicine unit (FMU). Methods: analytical crosssectional study; 121 adults aged 60 years and over attached to the fmu No.20 of the Mexican Institute of Social Security (IMSS) in Caucel, Yucatan, Mexico participated; they were evaluated from June to October 2019. Using a non-randomized sampling of consecutive cases, the sociodemographic data and body mass index (BMI) were collected. The diagnosis of sarcopenia was established according to criteria of the European Working Group on Sarcopenia in Older People (EWGSOP 2010). The Rapid Assessment of Physical Activity (RAPA) questionnaire was used to assess the level of physical activity and the Katz index to estimate dependence in activities of daily living. In the statistical analysis, the Mann-Whitney U and the χ² test of independence were used to compare the groups, and multiple logistic regression was used to determine risk factors for sarcopenia; a p-value ‹0.05 was considered significant. Results: the prevalence of sarcopenia was 46%. The factors associated with sarcopenia were: age ›75 years (OR of 6.3; 95% CI: 1.8- 21.4), chronic alcohol consumption (OR of 4.3; 95% CI: 1.45-13.2), BMI ‹27 (OR of 8; 95% CI: 1.8-33.9) and BMI of 27 to 30 (OR of 4.1; 95% CI: 1.64-10.5). Conclusions: sarcopenia was present in almost half of the participants; the risk of sarcopenia increases after 75 years of age, with chronic alcohol consumption and bmi ‹30.

REFERENCES

1. Organizacion Mundial de la Salud. La salud mental y los adultos mayores [Internet]. [Citado 2018 Jun 20]. Disponible en: http://www.who.int/es/ news-room/fact-sheets/detail/la-salud-mental-ylos- adultos-mayores.

2. Rivera-Silva, Gerardo. Rodríguez-Reyes, Leonardo. Treviño-Alanís MG. El envejecimiento de la población mexicana The aging of Mexican population. Rev Med Inst Mex Seguro Soc. 2018;56(1):116.

3. INEGI. “Estadísticas a propósito del día internacional de las personas de edad” mayores [Internet]. [Citado 2018 Jun 20]. Disponible en: http:// www.parametria.com.mx/estudios/estadisticas-aproposito- del-dia-internacional-de-las-personasde- edad-adultos-mayores/

4. Instituto Nacional de Estadística y Geografía (México). Indicadores 2015 / Instituto Nacional de Estadística y Geografía mayores [Internet]. [Citado 20120 Nov 10]. Disponible en: https://www.inegi. org.mx/app/descarga/?ag=31&ti=7.

5. Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48:16-31.

6. Rojas Bermúdez C, Buckcanan Vargas A, Benavides Jiménez G. Sarcopenia: abordaje integral del adulto mayor. Rev Medica Sinerg. 2019;4(5):24–34.

7. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: A systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16(1):1-10.

8. Espinel-Bermúdez M, Sánchez-García S, García- Peña C, Trujillo X, Huerta-Viera M, Granados- García V, et al. Factores asociados a sarcopenia en adultos mayores mexicanos: Encuesta Nacional de Salud y Nutrición 2012. Rev Médica del Insituto Mex del Seguro Soc. 2018;56(Supl1):S46-53.

9. Woo J. Sarcopenia. Clin Geriatr Med. 2017;33(3):305-14.

10. Li CI, Li TC, Lin WY, Liu CS, Hsu CC, Hsiung CA, et al. Sarcopenia and Translational Aging Research in Taiwan (START) Team. Combined association of chronic disease and low skeletal muscle mass with physical performance in older adults in the Sarcopenia and Translational Aging Research in Taiwan (START) study. BMC Geriatr. 2015;15:11.

11. Kwon YJ, Lim HJ, Lee YJ, Lee HS, Linton JA, Lee JW, et al. Associations between high-risk alcohol consumption and sarcopenia among postmenopausal women. Menopause. 2017;24(9):1022–7.

12. Steffl M, Bohannon RW, Petr M, Kohlikova E, Holmerova I. Relation between cigarette smoking and sarcopenia: Meta-analysis. Physiol Res. 2015;64(3):419-26.

13. Instituto Nacional de Estadística y Geografía (México). Encuesta Nacional de Salud y Nutrición [Internet]. [Citado 2020 Ene 14]. Disponible en: https://www.inegi.org.mx/contenidos/programas/ ensanut/2018/doc/ensanut_2018_presentacion_ resultados.pdf

14. Evaluación y seguimiento nutricional del adulto mayor en el primer nivel de atención. méxico: Secretaría de salud; 11 de diciembre de 2014. [Internet]. [Citado 2018 Jun 20]. Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/ CatalogoMaestro/095_GPC_Evaycontrolnutic_ eneladultomayor/NUTRICION_AM_RR_CENETEC. pdf

15. Kelley GA, Kelley KS, Ed M. Short Report: Is Sarcopenia Associated with an Increased Risk of All- Cause Mortality and Functional Disability? Exp Gerontol. 2018;96:100-103.

16. Martínez V, Herrera A, Cabrera F. Sarcopenia y fragilidad en adultos mayores hospitalizados en salas medicina interna. Acta Med Colomb. 2020;45(1):1-9.

17. Espinel-Bermúdez M, Ramírez García E, García Peña C, Salvà A, L RA. Prevalence of sarcopenia in community ‐ dwelling older people of Mexico City using the EGWSOP (European Working Group on Sarcopenia in Older People) diagnostic criteria. J Cachexia, Sarcopenia Muscle ‐ Clin Reports. 2017;2(2):1-9.

18. Gaytán MV, Rodríguez MGVA, Ruiz NM, Romero RU. Calidad de Vida del adulto mayor desamparado, asilado en Ciudad Juárez Chihuahua, México. Ehquidad Int Welf Policies Soc Work J. 2019;12:177-90.

19. Hernández-Rodríguez J, Licea-Puig ME. Generalidades y tratamiento de la Sarcopenia. Rev Médicas UIS. 2017;30(3):71-81.

20. Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48:16-31.